PT  - JOURNAL ARTICLE
AU  - Hoyle, Brian
ED  - Pagani, Olivia
TI  - Comparison of Treatments for HR+ Early Breast Cancer
DP  - 2014 Aug 01
TA  - MD Conference Express
PG  - 9--11
VI  - 14
IP  - 14
4099  - http://mdc.sagepub.com/content/14/14/9.short
4100  - http://mdc.sagepub.com/content/14/14/9.full
AB  - This article presents the joint analysis of 2 randomized comparative trials coordinated by the International Breast Cancer Study Group, the Tamoxifen and Exemestane Trial [TEXT; NCT0006670] and the Suppression of Ovarian Function Trial [SOFT; NCT00066690]. The trials compared adjuvant exemestane plus ovarian function suppression versus tamoxifen plus ovarian function suppression in the treatment of premenopausal women with hormone receptor—positive (HR+) early breast cancer [Pagani O et al. J Clin Oncol 2014].